What patent is Iqirvo tied to?
“Iqirvo” (elobritinib) is associated with pharmaceutical patent protection that covers the drug and its composition/use. The exact patents and their claim scope depend on the jurisdiction (for example, US vs. Europe) and on the specific filing(s) that were listed for regulatory exclusivity or patent listings.
When do Iqirvo patents expire?
Patent expiry for Iqirvo varies by country because patents are granted and expire on different schedules. Expiry also can differ from regulatory exclusivity dates. To answer precisely, you need:
- the country (e.g., United States, EU, UK)
- the exact patent number(s) or a regulator’s patent listing entry
Are there biosimilar or generic challenges to Iqirvo?
If a company files an application seeking earlier market entry (for example, under generic or follow-on pathways), it can trigger patent litigation around infringement and validity. Whether Iqirvo has active challenges depends on the latest filings and court dockets in each jurisdiction.
What patents matter for market exclusivity—composition, formulation, or method-of-use?
For small-molecule oncology drugs like Iqirvo, the patents that most often affect market entry are:
- composition-of-matter (the core drug)
- method-of-use (specific therapeutic indications)
- sometimes formulations/dosing regimens or manufacturing processes
Which of these are “in force” for blocking competitors depends on the active patents in that country and whether any have been narrowed or invalidated.
How can you find the exact Iqirvo patent numbers quickly?
The most reliable way is to search patent listings tied to the product in the target jurisdiction (for example, regulator-linked patent registers) and then cross-check with the patent office record for each patent number.
What I need from you to give the exact patent answer
Tell me which you mean by “Iqirvo patent”:
1) the patent number(s) (US/EU/UK/etc.)
2) the next expected expiry date
3) whether there are challenges/lawsuits
4) patents specific to a particular indication
Also share the country you care about (or “US and EU”).